Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis

Life Science Alliance(2024)10.26508/lsa.202302229Source: DataRank Database

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis is a research paper published in Life Science Alliance (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.37)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Niousha Ahmari,Ashley Hall ORCID,Mark Jackson ORCID,Youjin Na,Jay Pundavela ORCID

Live enrichment

PubMed:38458648 PMC:PMC10923703 OpenAlex:https://openalex.org/W4392601211

HHS | NIH | National Institute of Neurological Disorders and Stroke

Grant: R61/R33 NS112407

NINDS NIH HHS

Grant: R33 NS112407

NINDS NIH HHS

Grant: R61 NS112407

FWCI

1.37

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://www.life-science-alliance.org/content/lsa/7/5/e202302229.full.pdf

publisherhttps://www.life-science-alliance.org/content/lsa/7/5/e202302229.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.26508/lsa.202302229

journalhttps://doi.org/10.26508/lsa.202302229

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38458648

Fields of Study

Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsNerve injury and regenerationHumansCytophagocytosisMacrophagesMitogen-Activated Protein Kinase KinasesNeurofibroma, PlexiformSignal TransductionTumor MicroenvironmentReceptor, Anaphylatoxin C5a

MeSH Terms

HumansMacrophagesSignal TransductionNeurofibroma, PlexiformMitogen-Activated Protein Kinase KinasesReceptor, Anaphylatoxin C5aCytophagocytosisTumor Microenvironment

Keywords

MAPK/ERK pathwayApoptosisMEK inhibitorMacrophageProgrammed cell deathCancer researchPhagocytosisSchwann cellCell biologyChemistryBiologySignal transduction

Sustainable Development Goals

SDG 0: Good health and well-being